FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kieren Marr

Research Profile

Chemicals & Drugs

Disorders

Procedures

Living Beings

Concepts & Ideas

Physiology

Fungal Drug Resistance

Co-author Network

Publications

TOP 3
Jennifer L Lyons; Kieren Marr; Henry Neumann; Karen L Roos; Lisa Steiner; Kiran T Thakur; Julie B Trivedi; Daniel M Harrison; Dorlan J Kimbrough; Sean X Zhang
Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.
S F Dufresne; R E LeBlanc; Kieren Marr; S X Zhang; Dionissios Neofytos
Histoplasmosis and subcutaneous nodules in a kidney transplant recipient: erythema nodosum versus fungal panniculitis.
Dionissios Neofytos; Darin Bruce Ostrander; ARUNA SUBRAMANIAN; CAROL THOMPSON; S Treadway; C D Alonso; J Cady-Reh; Niraj Desai; M Harris; K Kobayashi; Edward Kraus; D Lepley; Kieren Marr
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kieren Marr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer L Lyons; Kieren Marr; Henry Neumann; Karen L Roos; Lisa Steiner; Kiran T Thakur; Julie B Trivedi; Daniel M Harrison; Dorlan J Kimbrough; Sean X Zhang
Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.
Journal of clinical microbiology 2013;51(4):1285-7.
2013: S F Dufresne; R E LeBlanc; Kieren Marr; S X Zhang; Dionissios Neofytos
Histoplasmosis and subcutaneous nodules in a kidney transplant recipient: erythema nodosum versus fungal panniculitis.
Transplant infectious disease : an official journal of the Transplantation Society 2013;15(2):E58-63.
2013: Dionissios Neofytos; Darin Bruce Ostrander; ARUNA SUBRAMANIAN; CAROL THOMPSON; S Treadway; C D Alonso; J Cady-Reh; Niraj Desai; M Harris; K Kobayashi; Edward Kraus; D Lepley; Kieren Marr
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2013;15(2):134-41.
2013: Christopher R Flowers; Charise Gleason; Douglas K Hawley; Clare Karten; Nicole M Kuderer; Amelia A Langston; Kieren Marr; Kenneth V I Rolston; Jerome Seidenfeld; Eric J Bow; Scott D Ramsey
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(6):794-810.
2013: Shmuel Shoham; Kieren Marr
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
Annals of internal medicine 2013;158(3):208-10.
2013: Dionissios Neofytos; Veronique Nussenblatt; Darin Bruce Ostrander; Suzanne Treadway; Amanda Blackford; Amy Hatfield-Seung; Kit Lu; Kieren Marr; Judith E Karp
Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy.
Diagnostic microbiology and infectious disease 2013;75(2):144-9.
2013: John W Baddley; Michael Boeckh; Kyle D Brizendine; Tom M Chiller; James I Ito; Carol A Kauffman; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren Marr; Robert A Oster; Thomas Patterson; Mindy G Schuster; David Andes; Peter G Pappas
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2013;51(2):128-35.
2012: Lindsey Robert Baden; William Bensinger; Corey Casper; Erik R Dubberke; Alison G Freifeld; Ramiro Garzon; John N Greene; John P Greer; James I Ito; Judith E Karp; Daniel Kaul; Earl King; Emily Mackler; Kieren Marr; Jose G Montoya; Ashley Morris-Engemann; Maoko Naganuma; Peter G Pappas; Ken Rolston; Brahm Segal; Susan K Seo; Dorothy A Shead; Sankar Swaminathan; Michael Angarone
Prevention and treatment of cancer-related infections.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(11):1412-45.
2012: William J Steinbach; Kieren Marr; Herwig-Ulf Meier-Kriesche; Shun-Ping Quan; Elias J Anaissie; Senu Apewokin; Nkechi Azie; David L Horn
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
The Journal of infection 2012;65(5):453-64.
2012: Zina Meriden; Stefan Riedel; Kathryn Villa; Karen C Carroll; PETER ILLEI; Howard M Lederman; Kieren Marr; Sean X Zhang
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2012;50(8):883-9.
2012: Dionissios Neofytos; Shmuel Shoham; Sean X Zhang; Kerry Dierberg; Simon Dufresne; Katharine Le; Kieren Marr
Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis.
Diagnostic microbiology and infectious disease 2012;73(4):374-5.
2012: Kieren Marr
Cryptococcus gattii as an important fungal pathogen of western North America.
Expert review of anti-infective therapy 2012;10(6):637-43.
2012: Kerry Dierberg; J E Locke; Kieren Marr; Heather Nace; C Chamberlain; Niraj Desai; J Diaz; ARUNA SUBRAMANIAN; S Zhang; Dionissios Neofytos
Donor-derived organ transplant transmission of coccidioidomycosis.
Transplant infectious disease : an official journal of the Transplantation Society 2012;14(3):300-4.
2012: Shmuel Shoham; Kieren Marr
Invasive fungal infections in solid organ transplant recipients.
Future microbiology 2012;7(5):639-55.
2012: Carolyn D Alonso; Karen C Carroll; David B Hanna; Carol Ann Huff; Dionissios Neofytos; Suzanne B Treadway; Kieren Marr
Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(8):1053-63.
2012: Dionissios Neofytos; M Hong Nguyen; Darin Bruce Ostrander; Ryan K Shields; CAROL THOMPSON; Lindsay Warren; Lindsey R Lombardi; Kieren Marr
Administration of voriconazole in patients with renal dysfunction.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(7):913-21.
2012: Neelkamal Chaudhary; Kausik Datta; Frederic B Askin; Janet F. Staab; Kieren Marr
Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation.
American journal of respiratory and critical care medicine 2012;185(3):301-10.
2012: Debasish Sundi; Kenneth Tseng; Kieren Marr; Jeffrey K Mullins; Matthew Eric Hyndman
Invasive fungal bezoar requiring partial cystectomy.
Urology 2012;79(2):e21-2.
2012: Kieren Marr
Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():265-70.
2012: Simon F Dufresne; Marta Feldmesser; Xinming Li; Ekaterina Dadachova; Kausik Datta; Thomas Patterson; Janet F. Staab; Kieren Marr
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.
PloS one 2012;7(8):e42736.
2012: Kieren Marr; Kausik Datta; Liise-anne Pirofski; Robert Barnes
Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(1):153-4.
2011: Kieren Marr
Cryptococcus gattii: the tip of the iceberg.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(12):1196-8.
2011: Benjamin Park; Thomas Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; THOMAS WALSH; Kathleen A Wannemuehler; John R Wingard; Barbara D Alexander; Elias J Anaissie; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; James I Ito; Carol A Kauffman; G Marshall Lyon; Kieren Marr; Vicki A Morrison; Genovefa Papanicolaou; Peter G Pappas; Dimitrios P Kontoyiannis
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Emerging infectious diseases 2011;17(10):1855-64.
2011: Laurel Garrett; Kieren Marr; Sarah West; Gopal Allada
74-year-old man from the pacific northwest with fever and a lung mass.
Chest 2011;140(3):814-7.
2011: Shawn R Lockhart; Kieren Marr; Peter G Pappas; THOMAS WALSH; Alicia J Zimbeck; David R Andes; John W Baddley; James I Ito; Carol A Kauffman; Dimitrios P Kontoyiannis; Tom Chiller
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
Antimicrobial agents and chemotherapy 2011;55(8):3944-6.
2011: C M Durand; N P Kwiatkowski; C D Alonso; Karen C Carroll; Margaret Mary Showel; A P Subhawong; Kieren Marr
Rapidly progressive cutaneous Rhizopus microsporus infection presenting as Fournier's gangrene in a patient with acute myelogenous leukemia.
Transplant infectious disease : an official journal of the Transplantation Society 2011;13(4):392-6.
2011: Edmond J Byrnes; Kieren Marr
The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues.
Current infectious disease reports 2011;13(3):256-61.
2011: Neelkamal Chaudhary; Kieren Marr
Impact of Aspergillus fumigatus in allergic airway diseases.
Clinical and translational allergy 2011;1(1):4.
2011: Andrew H Limper; Kenneth S Knox; George A Sarosi; Neil M Ampel; JOHN BENNETT; Antonino Catanzaro; Scott F Davies; William E Dismukes; Chadi A Hage; Kieren Marr; Christopher H Mody; John R Perfect; David A Stevens
An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.
American journal of respiratory and critical care medicine 2011;183(1):96-128.
2011: Janet F. Staab; Theodore C White; Kieren Marr
Hairpin dsRNA does not trigger RNA interference in Candida albicans cells.
Yeast (Chichester, England) 2011;28(1):1-8.
2010: John R Wingard; Shelly L Carter; THOMAS WALSH; Joanne Kurtzberg; Trudy N Small; Lindsey R Baden; Iris D Gersten; Adam M Mendizabal; Helen L Leather; Dennis L Confer; Richard T Maziarz; Edward A Stadtmauer; Javier Bolaños-Meade; Janice Brown; John F Dipersio; Michael Boeckh; Kieren Marr
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
Blood 2010;116(24):5111-8.
2010: Janet F. Staab; Jennifer Nielsen Kahn; Kieren Marr
Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
Antimicrobial agents and chemotherapy 2010;54(12):4992-8.
2010: Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Reduced mortality after allogeneic hematopoietic-cell transplantation.
The New England journal of medicine 2010;363(22):2091-101.
2010: Deepali Kumar; Marian G Michaels; Michele Morris; Michael Green; Robin K Avery; Catherine Liu; Lara Danziger-Isakov; Valentina Stosor; Michele Estabrook; Soren Gantt; Kieren Marr; Stanley Martin; Fernanda P Silveira; Raymund R Razonable; Upton D Allen; Marilyn E Levi; G Marshall Lyon; Lorraine E Bell; Shirish Huprikar; Gopi Patel; Kevin S Gregg; Kenneth Pursell; Doug Helmersen; Kathleen G Julian; Kevin Shiley; Bartholomew Bono; Vikas R Dharnidharka; Gelareh Alavi; Jayant S Kalpoe; Shmuel Shoham; Gail Reid; Atul Humar
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.
The Lancet infectious diseases 2010;10(8):521-6.
2010: Huei-Fung Tsai; Lindsay R Sammons; Xiaozhen Zhang; Sara D Suffis; Qin Su; Timothy G Myers; Kieren Marr; JOHN BENNETT
Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates.
Antimicrobial agents and chemotherapy 2010;54(8):3308-17.
2010: Anil A Panackal; Hong Li; Dimitrios P Kontoyiannis; Motomi Mori; Cheryl A Perego; Michael Boeckh; Kieren Marr
Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1588-97.
2010: John W Baddley; David Andes; Kieren Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; THOMAS WALSH; Mindy G Schuster; John R Wingard; Thomas Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Factors associated with mortality in transplant patients with invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1559-67.
2010: Kieren Marr; ARUNA SUBRAMANIAN
Transplantation represents one of the true modern advances in medicine, presenting new and effective treatments for organ and bone marrow failure and neoplastic disorders. Preface.
Infectious disease clinics of North America 2010;24(2):xiii-v.
2010: Dionissios Neofytos; J A Fishman; David Horn; E Anaissie; C-H Chang; Ali S Olyaei; Michael A Pfaller; W J Steinbach; K M Webster; Kieren Marr
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2010;12(3):220-9.
2010: Dimitrios P Kontoyiannis; Kieren Marr; Benjamin Park; Barbara D Alexander; Elias J Anaissie; THOMAS WALSH; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa A Papanicolaou; Thomas Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(8):1091-100.
2010: Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen A Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren Marr; Vicki A Morrison; Benjamin Park; Thomas Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; THOMAS WALSH; Kathleen A Wannemuehler; Tom M Chiller
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(8):1101-11.
2010: Kieren Marr
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment.
Current opinion in oncology 2010;22(2):138-42.
2010: Neelkamal Chaudhary; Janet F. Staab; Kieren Marr
Healthy human T-Cell Responses to Aspergillus fumigatus antigens.
PloS one 2010;5(2):e9036.
2010: Janyce A Sugui; Donald Vinh; G Nardone; Yvonne R Shea; Yun C Chang; Adrian M Zelazny; Kieren Marr; Steven M Holland; Kyung J Kwon-Chung
Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus?
Journal of clinical microbiology 2010;48(1):220-8.
2009: Kieren Marr; E Bow; T Chiller; G Maschmeyer; P Ribaud; B Segal; W Steinbach; John R Wingard; M Nucci
Fungal infection prevention after hematopoietic cell transplantation.
Bone marrow transplantation 2009;44(8):483-7.
2009: Kieren Marr; Wendy Leisenring; Eric J Bow
Empirical versus preemptive antifungal therapy for fever during neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(7):1138-9; author reply 1139-40.
2009: John W Baddley; Kieren Marr; David Andes; THOMAS WALSH; Carol A Kauffman; Dimitrios P Kontoyiannis; James I Ito; S Arunmozhi Balajee; Peter G Pappas; Stephen A Moser
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.
Journal of clinical microbiology 2009;47(10):3271-5.
2009: S Arunmozhi Balajee; Rui Kano; John W Baddley; Stephen A Moser; Kieren Marr; Barbara D Alexander; David Andes; Dimitrios P Kontoyiannis; Giancarlo Perrone; Stephen Peterson; Mary E Brandt; Peter G Pappas; Tom M Chiller
Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.
Journal of clinical microbiology 2009;47(10):3138-41.
2009: J A Davis; D L Horn; Kieren Marr; Jay A Fishman
Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):432-7.
2009: Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren Marr
Spread of Cryptococcus gattii into Pacific Northwest region of the United States.
Emerging infectious diseases 2009;15(8):1185-91.
2009: Janet F. Staab; S Arunmozhi Balajee; Kieren Marr
Aspergillus section Fumigati typing by PCR-restriction fragment polymorphism.
Journal of clinical microbiology 2009;47(7):2079-83.
2009: David L Horn; Dionissios Neofytos; Elias J Anaissie; Jay A Fishman; William J Steinbach; Ali S Olyaei; Kieren Marr; Michael A Pfaller; Chi-Hsing Chang; Karen M Webster
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(12):1695-703.
2009: Edmond J Byrnes; Robert J Bildfell; Sheryl A Frank; Thomas G Mitchell; Kieren Marr; Joseph Heitman
Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States.
The Journal of infectious diseases 2009;199(7):1081-6.
2009: Marco Mielcarek; Barry E Storer; Michael Boeckh; Paul A Carpenter; George B McDonald; H Joachim Deeg; Richard A Nash; Mary E D Flowers; Kristine C Doney; Stephanie Lee; Kieren Marr; Terry Furlong; Rainer Storb; Frederick R Appelbaum; Paul J Martin
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2009: Dionissios Neofytos; D Horn; E Anaissie; W Steinbach; Ali S Olyaei; J Fishman; M Pfaller; C Chang; K Webster; Kieren Marr
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):265-73.
2009: Dimitrios P Kontoyiannis; Voravit Ratanatharathorn; J-A Young; J Raymond; M Laverdière; D W Denning; Thomas Patterson; D Facklam; L Kovanda; L Arnold; W Lau; D Buell; Kieren Marr
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(1):89-93.
2009: Kausik Datta; Karen H Bartlett; Kieren Marr
Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche.
Interdisciplinary perspectives on infectious diseases 2009;2009():176532.
2009: Dimitrios P Kontoyiannis; Russell E Lewis; Kieren Marr
The burden of bacterial and viral infections in hematopoietic stem cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):128-33.
2008: Pierre-Yves Bochud; Jason W Chien; Kieren Marr; Wendy M Leisenring; Arlo Upton; Marta Janer; Stephanie D Rodrigues; Sarah Li; John A Hansen; Lue Ping Zhao; Alan Aderem; Michael Boeckh
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
The New England journal of medicine 2008;359(17):1766-77.
2008: Carol Garcia-Vidal; Arlo Upton; Katharine A Kirby; Kieren Marr
Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1041-50.
2008: Kieren Marr
Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.
Current opinion in infectious diseases 2008;21(4):409-14.
2008: Bart L Scott; J Y Park; H Joachim Deeg; Kieren Marr; Michael Boeckh; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb; Barry E Storer
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Ben De Pauw; THOMAS WALSH; J Peter Donnelly; David A Stevens; John Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; JOHN BENNETT
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1813-21.
2008: Aimee K Zaas; Guochun Liao; Jason W Chien; Clarice Weinberg; David Shore; Steven S Giles; Kieren Marr; Jonathan Usuka; Lauranell H Burch; Lalith Perera; John R Perfect; Gary Peltz; David A Schwartz
Plasminogen alleles influence susceptibility to invasive aspergillosis.
PLoS genetics 2008;4(6):e1000101.
2008: Kieren Marr
Fungal infections in hematopoietic stem cell transplant recipients.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2008;46(4):293-302.
2008: Kieren Marr
Aspergillus galactomannan index: a surrogate end point to assess outcome of therapy?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(9):1423-5.
2008: Camille Bretz; Geoffrey M Gersuk; Sue Knoblaugh; Neelkamal Chaudhary; Julie Randolph-Habecker; Robert C Hackman; Janet F. Staab; Kieren Marr
MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus.
Infection and immunity 2008;76(3):952-8.
2008: THOMAS WALSH; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne H van Burik; John R Wingard; Thomas Patterson
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):327-60.
2008: Geoffrey M Gersuk; Leon W Razai; Kieren Marr
Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1.
Journal of immunological methods 2008;329(1-2):157-66.
2007: David Horn; Dionissios Neofytos; J Fishman; W Steinbach; E Anaisie; Kieren Marr; Michael A Pfaller; Ali S Olyaei
Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(12):907-14.
2007: David L Horn; Jay A Fishman; William J Steinbach; Elias J Anaissie; Kieren Marr; Ali S Olyaei; Michael A Pfaller; Mark A Weiss; Karen M Webster; Dionissios Neofytos
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
Diagnostic microbiology and infectious disease 2007;59(4):407-14.
2007: Penelope Barnes; Kieren Marr
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.
British journal of haematology 2007;139(4):519-31.
2007: Arlo Upton; James A Fraser; Sarah E Kidd; Camille Bretz; Karen H Bartlett; Joseph Heitman; Kieren Marr
First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak.
Journal of clinical microbiology 2007;45(9):3086-8.
2007: Arlo Upton; Jeannine S McCune; Katharine A Kirby; Wendy Leisenring; George McDonald; Ami Batchelder; Kieren Marr
Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):760-4.
2007: Jennifer Nielsen Kahn; Guillermo Garcia-Effron; Ming-Jo Hsu; Steven Park; Kieren Marr; David Perlin
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
Antimicrobial agents and chemotherapy 2007;51(5):1876-8.
2007: Arlo Upton; Katharine A Kirby; Paul Carpenter; Michael Boeckh; Kieren Marr
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(4):531-40.
2006: S Arunmozhi Balajee; Kieren Marr
Phenotypic and genotypic identification of human pathogenic aspergilli.
Future microbiology 2006;1(4):435-45.
2006: Jin Woo Bok; DaWoon Chung; S Arunmozhi Balajee; Kieren Marr; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Katharine A Kirby; Nancy P Keller
GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence.
Infection and immunity 2006;74(12):6761-8.
2006: Arlo Upton; Kieren Marr
Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient.
Current infectious disease reports 2006;8(6):434-41.
2006: Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Mónica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver A Cornely; Ann E Hunter; Kieren Marr; Hans Jürgen Dornbusch; Hermann Einsele
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2006;108(9):2928-36.
2006: David W Denning; Kieren Marr; Wendi M Lau; David P Facklam; Voravit Ratanatharathorn; Cornelia Becker; Andrew J Ullmann; Nita L Seibel; Patricia M Flynn; Jo-Anne H van Burik; Donald N Buell; Thomas Patterson
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
The Journal of infection 2006;53(5):337-49.
2006: Jenna B Allard; Matthew E Poynter; Kieren Marr; Lauren Cohn; Mercedes Rincon; Laurie A Whittaker
Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(8):5186-94.
2006: celalettin ustun; Gerwin Huls; Marc Stewart; Kieren Marr
Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor.
Mycopathologia 2006;162(4):299-302.
2006: S Arunmozhi Balajee; David C Nickle; Janos Varga; Kieren Marr
Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping.
Eukaryotic cell 2006;5(10):1705-12.
2006: Penelope Barnes; Kieren Marr
Aspergillosis: spectrum of disease, diagnosis, and treatment.
Infectious disease clinics of North America 2006;20(3):545-61, vi.
2006: Morgan B Hakki; Janet F. Staab; Kieren Marr
Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
Antimicrobial agents and chemotherapy 2006;50(7):2522-4.
2006: Anil A Panackal; Jennifer L Gribskov; Janet F. Staab; Katherine A Kirby; Michael Rinaldi; Kieren Marr
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Journal of clinical microbiology 2006;44(5):1740-3.
2006: Donald C Sheppard; Kieren Marr; David N Fredricks; Lisa Y Chiang; Thomas Doedt; Scott Filler
Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(4):376-80.
2006: Arlo Upton; Wendy Leisenring; Kieren Marr
(1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(7):1054-6; author reply 1056.
2006: Geoffrey M Gersuk; David M Underhill; Liqun Zhu; Kieren Marr
Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3717-24.
2006: Anil A Panackal; Alexander Imhof; Edward W Hanley; Kieren Marr
Aspergillus ustus infections among transplant recipients.
Emerging infectious diseases 2006;12(3):403-8.
2006: Richard N Greenberg; K Mullane; Jo-Anne H van Burik; I Raad; M J Abzug; Gregory M Anstead; Raoul Herbrecht; A Langston; Kieren Marr; Gary J Schiller; M Schuster; J R Wingard; Corina Gonzalez; Sanjay G Revankar; Gavin Corcoran; R J Kryscio; Roberta S Hare
Posaconazole as salvage therapy for zygomycosis.
Antimicrobial agents and chemotherapy 2006;50(1):126-33.
2005: S Arunmozhi Balajee; Jennifer L Gribskov; Mary Brandt; James Ito; Annette Fothergill; Kieren Marr
Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus.
Journal of clinical microbiology 2005;43(12):5996-9.
2005: Kieren Marr; Wendy Leisenring
Design issues in studies evaluating diagnostic tests for aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 6():S381-6.
2005: Jin Woo Bok; S Arunmozhi Balajee; Kieren Marr; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
LaeA, a regulator of morphogenetic fungal virulence factors.
Eukaryotic cell 2005;4(9):1574-82.
2005: Arlo Upton; Anja Gugel; Wendy Leisenring; Ajit P Limaye; Barbara Alexander; Randall Hayden; Kieren Marr
Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.
Journal of clinical microbiology 2005;43(9):4796-800.
2005: Marcio Nucci; Kieren Marr
Emerging fungal diseases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(4):521-6.
2005: Kieren Marr; Michel Laverdiere; Anja Gugel; Wendy Leisenring
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(12):1762-9.
2005: J Morgan; Kathleen A Wannemuehler; Kieren Marr; S Hadley; D P Kontoyiannis; THOMAS WALSH; Scott K Fridkin; Peter G Pappas; David W Warnock
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S49-58.
2005: Geoffrey M Gersuk; Atsunobu Hiraoka; Kieren Marr
Human monocytes differentiate into macrophages under the influence of human KPB-M15 conditioned medium.
Journal of immunological methods 2005;299(1-2):99-106.
2005: S Arunmozhi Balajee; Jennifer L Gribskov; Edward Hanley; David C Nickle; Kieren Marr
Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.
Eukaryotic cell 2005;4(3):625-32.
2005: S Arunmozhi Balajee; Alexander Imhof; Jennifer L Gribskov; Kieren Marr
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
The Journal of antimicrobial chemotherapy 2005;55(1):102-5.
2004: Kieren Marr
Invasive Candida infections: the changing epidemiology.
Oncology (Williston Park, N.Y.) 2004;18(14 Suppl 13):9-14.
2004: Banu Sancak; John H Rex; Enuo Chen; Kieren Marr
Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.
Journal of clinical microbiology 2004;42(12):5889-91.
2004: Benjamin Musher; David N Fredricks; Wendy Leisenring; S Arunmozhi Balajee; Caitlin Smith; Kieren Marr
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Journal of clinical microbiology 2004;42(12):5517-22.
2004: Kieren Marr
Combination antifungal therapy: where are we now, and where are we going?
Oncology (Williston Park, N.Y.) 2004;18(13 Suppl 7):24-9.
2004: Kieren Marr
Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39 Suppl 4():S170-5.
2004: Spencer Redding; Kieren Marr; William R Kirkpatrick; Brent J Coco; Thomas Patterson
Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(5):479-81.
2004: Kieren Marr; Michael Boeckh; Rachel A Carter; Hyung Woo Kim; Lawrence Corey
Combination antifungal therapy for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(6):797-802.
2004: Kieren Marr; R Hachem; Genovefa A Papanicolaou; J Somani; J M Arduino; C J Lipka; Angela Ngai; Nicholas A Kartsonis; J Chodakewitz; Carole A Sable
Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.
Transplant infectious disease : an official journal of the Transplantation Society 2004;6(3):110-6.
2004: Alexander Imhof; S Arunmozhi Balajee; David N Fredricks; Janet A Englund; Kieren Marr
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):743-6.
2004: Kieren Marr; S Arunmozhi Balajee; Lisa McLaughlin; MARC TABOURET; Christopher Bentsen; THOMAS WALSH
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.
The Journal of infectious diseases 2004;190(3):641-9.
2004: William J Steinbach; Daniel K Benjamin; Dimitrios P Kontoyiannis; John R Perfect; Irja Lutsar; Kieren Marr; Michail S Lionakis; Harrys A Torres; Hasan Jafri; THOMAS WALSH
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):192-8.
2004: Takahiro Fukuda; Michael Boeckh; Katherine A Guthrie; Debra K Mattson; Stephanie Owens; Anna Wald; Brenda M Sandmaier; Lawrence Corey; Rainer F Storb; Kieren Marr
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):494-503.
2004: Marcio Nucci; Kieren Marr; Flávio Queiroz-Telles; C A S Martins; Plinio Trabasso; Silvia Costa; Julio C Voltarelli; Arnaldo L Colombo; Alexander Imhof; Ricardo Pasquini; Angelo Maiolino; Cármino A Souza; Elias Anaissie
Fusarium infection in hematopoietic stem cell transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(9):1237-42.
2004: JOHN BENNETT; Koichi Izumikawa; Kieren Marr
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.
Antimicrobial agents and chemotherapy 2004;48(5):1773-7.
2004: Anil A Panackal; Kieren Marr
Scedosporium/Pseudallescheria infections.
Seminars in respiratory and critical care medicine 2004;25(2):171-81.
2004: S Arunmozhi Balajee; Molly Weaver; Alexander Imhof; Jennifer L Gribskov; Kieren Marr
Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals.
Antimicrobial agents and chemotherapy 2004;48(4):1197-203.
2004: Kieren Marr; Fulvio Crippa; Wendy Leisenring; Maggie Hoyle; Michael Boeckh; S Arunmozhi Balajee; W Garrett Nichols; Benjamin Musher; Lawrence Corey
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Blood 2004;103(4):1527-33.
2004: Kieren Marr; Wendy Leisenring; Fulvio Crippa; John T Slattery; Lawrence Corey; Michael Boeckh; George B McDonald
Cyclophosphamide metabolism is affected by azole antifungals.
Blood 2004;103(4):1557-9.
2004: Kieren Marr
Antifungal therapy for febrile neutropenia: issues in clinical trial design.
Current opinion in investigational drugs (London, England : 2000) 2004;5(2):202-7.
2003: Alexander Imhof; S Arunmozhi Balajee; Kieren Marr
New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
Journal of clinical microbiology 2003;41(12):5683-8.
2003: Kieren Marr
New approaches to invasive fungal infections.
Current opinion in hematology 2003;10(6):445-50.
2003: Kieren Marr; S Arunmozhi Balajee; Thomas R Hawn; Adrian Ozinsky; Uyenvy Pham; Shizuo Akira; Alan Aderem; W Conrad Liles
Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens.
Infection and immunity 2003;71(9):5280-6.
2003: Luis Ostrosky-Zeichner; Kieren Marr; John H Rex; Stuart H Cohen
Amphotericin B: time for a new "gold standard".
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(3):415-25.
2003: Takahiro Fukuda; Michael Boeckh; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Paul J Martin; Rainer F Storb; Kieren Marr
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Blood 2003;102(3):827-33.
2003: Thomas J Novicki; Karen LaFe; Lynda Bui; Uyen Bui; Robert Geise; Kieren Marr; Brad T Cookson
Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis.
Journal of clinical microbiology 2003;41(6):2623-8.
2003: John R Perfect; Kieren Marr; THOMAS WALSH; Richard N Greenberg; Bertrand Dupont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(9):1122-31.
2002: Kieren Marr; Rachel A Carter; Michael Boeckh; Paul Martin; Lawrence Corey
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
Blood 2002;100(13):4358-66.
2002: Kieren Marr; Thomas Patterson; David Denning
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
Infectious disease clinics of North America 2002;16(4):875-94, vi.
2002: Michael Boeckh; W Garrett Nichols; Kieren Marr
Long-term care after hematopoietic-cell transplantation in adults.
The New England journal of medicine 2002;347(20):1625-6; author reply 1625-6.
2002: Raoul Herbrecht; David W Denning; Thomas Patterson; JOHN BENNETT; Reginald E Greene; Jörg Oestmann; Winfried V Kern; Kieren Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter Troke; Ben de Pauw
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine 2002;347(6):408-15.
2002: S Arunmozhi Balajee; Kieren Marr
Conidial viability assay for rapid susceptibility testing of Aspergillus species.
Journal of clinical microbiology 2002;40(8):2741-5.
2002: Christian Junghanss; Kieren Marr
Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?
Current opinion in infectious diseases 2002;15(4):347-53.
2002: Justina Y Ju; Cynthia Polhamus; Kieren Marr; Steven M Holland; JOHN BENNETT
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Antimicrobial agents and chemotherapy 2002;46(5):1240-5.
2002: Kieren Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(7):909-17.
2002: Kieren Marr
Empirical antifungal therapy--new options, new tradeoffs.
The New England journal of medicine 2002;346(4):278-80.
2002: Christian Junghanss; Kieren Marr; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas R Chauncey; Peter A McSweeney; Rainer Storb
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
2002: Fulvio Crippa; Leona A Holmberg; Rachel A Carter; Heather A Hooper; Kieren Marr; William I Bensinger; Thomas R Chauncey; Lawrence Corey; Michael Boeckh
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):281-9.
2001: Kieren Marr
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Oncology (Williston Park, N.Y.) 2001;15(11 Suppl 9):15-9.
2001: Kieren Marr; M Koudadoust; M Black; S Arunmozhi Balajee
Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.
Clinical and diagnostic laboratory immunology 2001;8(6):1240-7.
2001: Kieren Marr
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Current opinion in infectious diseases 2001;14(4):423-6.
2001: Jan Storek; Monja A Dawson; Barry Storer; Terry Stevens-Ayers; David G Maloney; Kieren Marr; Robert P Witherspoon; William I Bensinger; Mary E D Flowers; P Martin; Rainer Storb; Frederick R Appelbaum; Michael Boeckh
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Kieren Marr; M Boeckh
Practice guidelines for fungal infections: a risk-guided approach.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(2):321.
2001: Kieren Marr; Chris N Lyons; K Ha; Tige R Rustad; Theodore C White
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
Antimicrobial agents and chemotherapy 2001;45(1):52-9.
2000: Kieren Marr; K Seidel; M A Slavin; Raleigh A Bowden; H Gary Schoch; Mary E D Flowers; Lawrence Corey; Michael Boeckh
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
Blood 2000;96(6):2055-61.
2000: AK Gopal; Vance G Fowler; Manish A Shah; Diane Gesty-Palmer; Kieren Marr; RS McClelland; LK Kong; GS Gottlieb; Kevin Lanclos; J Li; Daniel J Sexton; G Ralph Corey
Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1110-5.
2000: Kieren Marr
Staphylococcus aureus bacteremia in patients undergoing hemodialysis.
Seminars in dialysis 2000;13(1):23-9.
2000: GS Gottlieb; Vance G Fowler; LK Kong; RS McClelland; AK Gopal; Kieren Marr; J Li; Daniel J Sexton; D Glower; G Ralph Corey
Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility.
Journal of the American College of Surgeons 2000;190(1):50-7.
2000: Kieren Marr; K Seidel; Theodore C White; Raleigh A Bowden
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
The Journal of infectious diseases 2000;181(1):309-16.
1999: Kieren Marr; R A Bowden
Fungal infections in patients undergoing blood and marrow transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 1999;1(4):237-46.
1999: Kieren Marr; Tige R Rustad; J H Rex; Theodore C White
The trailing end point phenotype in antifungal susceptibility testing is pH dependent.
Antimicrobial agents and chemotherapy 1999;43(6):1383-6.
1998: Kieren Marr; L Kong; V G Fowler; A Gopal; D J Sexton; Peter J Conlon; G R Corey
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients.
Kidney international 1998;54(5):1684-9.
1998: Kieren Marr; Chris N Lyons; Tige R Rustad; Raleigh A Bowden; Theodore C White; T Rustad
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
Antimicrobial agents and chemotherapy 1998;42(10):2584-9.
1998: Vance G Fowler; Linda L Sanders; Daniel J Sexton; L Kong; Kieren Marr; AK Gopal; GS Gottlieb; RS McClelland; G Ralph Corey
Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(3):478-86.
1998: Theodore C White; Kieren Marr; Raleigh A Bowden
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
Clinical microbiology reviews 1998;11(2):382-402.
1998: Kieren Marr; Jan V Hirschmann; David R Thorning; Gregory J Raugi
Photo quiz. Protothecosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(3):575, 756-7.
1997: Kieren Marr; Theodore C White; Jo-Anne H van Burik; Raleigh A Bowden
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):908-10.
1997: Vance G Fowler; J Li; G Ralph Corey; J Boley; Kieren Marr; AK Gopal; LK Kong; GS Gottlieb; CL Donovan; Daniel J Sexton; Thomas Ryan
Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients.
Journal of the American College of Cardiology 1997;30(4):1072-8.
1997: Kieren Marr; Daniel J Sexton; Peter J Conlon; G Ralph Corey; Steve J Schwab; Kathryn B Kirkland
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis.
Annals of internal medicine 1997;127(4):275-80.